Quantinno Capital Management
MIRM icon

Quantinno Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Quantinno Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06M Sell
12,420
-5,825
-32% -$608K ﹤0.01% 2757
2026
Q2 		$2.14M Buy
18,245
+9,748
+115% +$979K ﹤0.01% 1917
2026
Q1 		$785K Buy
8,497
+5,305
+166% +$499K ﹤0.01% 2375
2025
Q4 		$252K Buy
3,192
+449
+16% +$32.2K ﹤0.01% 2936
2025
Q3 		$201K Buy
+2,743
New +$174K ﹤0.01% 2763

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Quantinno Capital Management's MIRM Position: Q3 2026 in Review

Quantinno Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 32% in Q3 2026, selling an estimated $608K and leaving 12,420 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Quantinno Capital Management first reported a position in MIRM in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.14M in Q2 2026. 221 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Quantinno Capital Management held 12,420 shares of Mirum Pharmaceuticals worth $1.06M as of Q3 2026.
  • Quantinno Capital Management sold 5,825 Mirum Pharmaceuticals shares in Q3 2026, an estimated $608K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2757 holding.
  • Quantinno Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Quantinno Capital Management's Mirum Pharmaceuticals position peaked at $2.14M in Q2 2026.
  • 221 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.